Kopp Lugli, Andrea
Marti, Walter R.
Salm, Lilian
Mujagic, Edin
Bundi, Marcel
von Strauss, Marco
Bucheli Laffer, Evelin
Landin, Julia
Fux, Christoph A.
Coslovsky, Michael
Weber, Walter Paul
Kindler, Christoph
Clinical trials referenced in this document:
Documents that mention this clinical trial
The Role of HbA1c as a Positive Perioperative Predictor of Surgical Site and Other Postoperative Infections: An Explorative Analysis in Patients Undergoing Minor to Major Surgery
https://doi.org/10.1007/s00268-021-06368-x
Funding for this research was provided by:
Universität Basel
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (138467)
Universität Basel
Universität Basel
Forschungsfond Research Council Kantonsspital Aarau AG, Switzerland
Gottfried und Julia Bangerter-Rhyner-Stiftung
Nora van Meeuwen-Häfliger Foundation
Hippocrate Foundation
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (138467)
University of Basel
Article History
Accepted: 24 October 2021
First Online: 8 November 2021
Change Date: 24 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00268-021-06392-x
Declarations
:
: The authors declare that they have no conflict of interest.
: The study protocol was approved by the appropriate institution review board and national research ethics committee in April 2012: Basel: reference number EK 19/12; Aarau: reference number EK 2011/037 and registered on ClinicalTrials.gov (NCT01790529). The SSI Trial was performed in compliance with the protocol and according to Good Clinical Practice standards and legal regulations. The authors adhered to the STROBE reporting guidelines for observational studies.
: Informed consent was obtained from all individual participants included in the study in accordance with the Helsinki Declaration.